68 GaGa-CXCR4 PET/CT imaging in high-grade glioma for assessment of CXCR4 receptor expression

Gliomas account for 75 % of primary malignant CNS tumors. High-grade glioma (CNS WHO grades 3 and 4) have an unfavorable treatment response and poor outcome. CXCR4 is a G protein-coupled receptor that plays an important part in the signaling pathway between cancer cells and tumor microenvironment. C...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of radiology 2024-11, Vol.180, p.111694
Hauptverfasser: Roustaei, Hessamoddin, Vosoughi, Habibeh, Askari, Emran, Aziz Kalantari, Bagher, Norouzbeigi, Nasim, Anvari, Kazem, Beheshti, Mohsen, Aryana, Kamran
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page 111694
container_title European journal of radiology
container_volume 180
creator Roustaei, Hessamoddin
Vosoughi, Habibeh
Askari, Emran
Aziz Kalantari, Bagher
Norouzbeigi, Nasim
Anvari, Kazem
Beheshti, Mohsen
Aryana, Kamran
description Gliomas account for 75 % of primary malignant CNS tumors. High-grade glioma (CNS WHO grades 3 and 4) have an unfavorable treatment response and poor outcome. CXCR4 is a G protein-coupled receptor that plays an important part in the signaling pathway between cancer cells and tumor microenvironment. CXCR4 overexpression has been shown in a variety of cancers. In this study, we evaluate the potential value of [68Ga]Ga-Pentixafor as a PET/CT CXCR4-probe for in vivo assessment of CXCR4 expression in patients with high-grade glioma and its correlation with tumor grade.PURPOSEGliomas account for 75 % of primary malignant CNS tumors. High-grade glioma (CNS WHO grades 3 and 4) have an unfavorable treatment response and poor outcome. CXCR4 is a G protein-coupled receptor that plays an important part in the signaling pathway between cancer cells and tumor microenvironment. CXCR4 overexpression has been shown in a variety of cancers. In this study, we evaluate the potential value of [68Ga]Ga-Pentixafor as a PET/CT CXCR4-probe for in vivo assessment of CXCR4 expression in patients with high-grade glioma and its correlation with tumor grade.[68Ga]Ga-CXCR4 PET/CT was performed in the prospective single-center study in treatment-naïve biopsy-proven patients with high-grade glioma. The acquired images were analyzed qualitatively and semi-quantitatively.MATERIALS AND METHODS[68Ga]Ga-CXCR4 PET/CT was performed in the prospective single-center study in treatment-naïve biopsy-proven patients with high-grade glioma. The acquired images were analyzed qualitatively and semi-quantitatively.A total of 26 patients (mean age: 53.3±14.4 years, 11 women, 15 men) were enrolled. CNS WHO grade 3 pathology was seen in 19 % (5/26) of the sample. The patient-based sensitivity of 68Ga-CXCR4 was 96.2 %. Overall, 28 pathologic lesions were detected, leading to a lesion-based sensitivity of 96.4 %. The median (IQR) SUVmax of grade 4 lesions was substantially greater than the grade 3(3.03(2.5-3.7) vs. 1.51(1.2-1.8), p = 0.0145).). The highest tracer activity of organs -beside bladder as the main excretion reservoir-was in lymphoid tissue of Waldeyer's ring (mean SUVmax: 7.41), and spleen (mean SUVmax: 6.62).RESULTA total of 26 patients (mean age: 53.3±14.4 years, 11 women, 15 men) were enrolled. CNS WHO grade 3 pathology was seen in 19 % (5/26) of the sample. The patient-based sensitivity of 68Ga-CXCR4 was 96.2 %. Overall, 28 pathologic lesions were detected, leading to a lesion-based sensitivity
doi_str_mv 10.1016/j.ejrad.2024.111694
format Article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_3099805016</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3099805016</sourcerecordid><originalsourceid>FETCH-proquest_miscellaneous_30998050163</originalsourceid><addsrcrecordid>eNqVjzurwkAUhBdR8PkLbE5pk7i7xjzq4PWWIilsRBY9WTcku3FPBH--gWthe6sZ-GYGhrGl4KHgIl5XIVZe3ULJZRQKIeIsGrCJSBMZJIlMhl9-zKZEFed8G2Vyws5xCnu1V0F-yo8RHHbFOi_ANEobq8FYuBt9D3Q_jqBr4xoFpfOgiJCoQduBK-Gv6_GKbddDfLW-p8bZORuVqiZcfHTGVj-7Iv8NWu8eT6Tu0hi6Yl0ri-5Jlw3PspRv-0ubf0TfrkBNLQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3099805016</pqid></control><display><type>article</type><title>68 GaGa-CXCR4 PET/CT imaging in high-grade glioma for assessment of CXCR4 receptor expression</title><source>Access via ScienceDirect (Elsevier)</source><creator>Roustaei, Hessamoddin ; Vosoughi, Habibeh ; Askari, Emran ; Aziz Kalantari, Bagher ; Norouzbeigi, Nasim ; Anvari, Kazem ; Beheshti, Mohsen ; Aryana, Kamran</creator><creatorcontrib>Roustaei, Hessamoddin ; Vosoughi, Habibeh ; Askari, Emran ; Aziz Kalantari, Bagher ; Norouzbeigi, Nasim ; Anvari, Kazem ; Beheshti, Mohsen ; Aryana, Kamran</creatorcontrib><description>Gliomas account for 75 % of primary malignant CNS tumors. High-grade glioma (CNS WHO grades 3 and 4) have an unfavorable treatment response and poor outcome. CXCR4 is a G protein-coupled receptor that plays an important part in the signaling pathway between cancer cells and tumor microenvironment. CXCR4 overexpression has been shown in a variety of cancers. In this study, we evaluate the potential value of [68Ga]Ga-Pentixafor as a PET/CT CXCR4-probe for in vivo assessment of CXCR4 expression in patients with high-grade glioma and its correlation with tumor grade.PURPOSEGliomas account for 75 % of primary malignant CNS tumors. High-grade glioma (CNS WHO grades 3 and 4) have an unfavorable treatment response and poor outcome. CXCR4 is a G protein-coupled receptor that plays an important part in the signaling pathway between cancer cells and tumor microenvironment. CXCR4 overexpression has been shown in a variety of cancers. In this study, we evaluate the potential value of [68Ga]Ga-Pentixafor as a PET/CT CXCR4-probe for in vivo assessment of CXCR4 expression in patients with high-grade glioma and its correlation with tumor grade.[68Ga]Ga-CXCR4 PET/CT was performed in the prospective single-center study in treatment-naïve biopsy-proven patients with high-grade glioma. The acquired images were analyzed qualitatively and semi-quantitatively.MATERIALS AND METHODS[68Ga]Ga-CXCR4 PET/CT was performed in the prospective single-center study in treatment-naïve biopsy-proven patients with high-grade glioma. The acquired images were analyzed qualitatively and semi-quantitatively.A total of 26 patients (mean age: 53.3±14.4 years, 11 women, 15 men) were enrolled. CNS WHO grade 3 pathology was seen in 19 % (5/26) of the sample. The patient-based sensitivity of 68Ga-CXCR4 was 96.2 %. Overall, 28 pathologic lesions were detected, leading to a lesion-based sensitivity of 96.4 %. The median (IQR) SUVmax of grade 4 lesions was substantially greater than the grade 3(3.03(2.5-3.7) vs. 1.51(1.2-1.8), p = 0.0145).). The highest tracer activity of organs -beside bladder as the main excretion reservoir-was in lymphoid tissue of Waldeyer's ring (mean SUVmax: 7.41), and spleen (mean SUVmax: 6.62).RESULTA total of 26 patients (mean age: 53.3±14.4 years, 11 women, 15 men) were enrolled. CNS WHO grade 3 pathology was seen in 19 % (5/26) of the sample. The patient-based sensitivity of 68Ga-CXCR4 was 96.2 %. Overall, 28 pathologic lesions were detected, leading to a lesion-based sensitivity of 96.4 %. The median (IQR) SUVmax of grade 4 lesions was substantially greater than the grade 3(3.03(2.5-3.7) vs. 1.51(1.2-1.8), p = 0.0145).). The highest tracer activity of organs -beside bladder as the main excretion reservoir-was in lymphoid tissue of Waldeyer's ring (mean SUVmax: 7.41), and spleen (mean SUVmax: 6.62).In conclusion, this new application for [68Ga]Ga-Pentixafor PET tracer exhibits excellent visual and semi-quantitative diagnostic properties. Further studies are warranted.CONCLUSIONIn conclusion, this new application for [68Ga]Ga-Pentixafor PET tracer exhibits excellent visual and semi-quantitative diagnostic properties. Further studies are warranted.</description><identifier>ISSN: 1872-7727</identifier><identifier>EISSN: 1872-7727</identifier><identifier>DOI: 10.1016/j.ejrad.2024.111694</identifier><language>eng</language><ispartof>European journal of radiology, 2024-11, Vol.180, p.111694</ispartof><rights>Copyright © 2024 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27929,27930</link.rule.ids></links><search><creatorcontrib>Roustaei, Hessamoddin</creatorcontrib><creatorcontrib>Vosoughi, Habibeh</creatorcontrib><creatorcontrib>Askari, Emran</creatorcontrib><creatorcontrib>Aziz Kalantari, Bagher</creatorcontrib><creatorcontrib>Norouzbeigi, Nasim</creatorcontrib><creatorcontrib>Anvari, Kazem</creatorcontrib><creatorcontrib>Beheshti, Mohsen</creatorcontrib><creatorcontrib>Aryana, Kamran</creatorcontrib><title>68 GaGa-CXCR4 PET/CT imaging in high-grade glioma for assessment of CXCR4 receptor expression</title><title>European journal of radiology</title><description>Gliomas account for 75 % of primary malignant CNS tumors. High-grade glioma (CNS WHO grades 3 and 4) have an unfavorable treatment response and poor outcome. CXCR4 is a G protein-coupled receptor that plays an important part in the signaling pathway between cancer cells and tumor microenvironment. CXCR4 overexpression has been shown in a variety of cancers. In this study, we evaluate the potential value of [68Ga]Ga-Pentixafor as a PET/CT CXCR4-probe for in vivo assessment of CXCR4 expression in patients with high-grade glioma and its correlation with tumor grade.PURPOSEGliomas account for 75 % of primary malignant CNS tumors. High-grade glioma (CNS WHO grades 3 and 4) have an unfavorable treatment response and poor outcome. CXCR4 is a G protein-coupled receptor that plays an important part in the signaling pathway between cancer cells and tumor microenvironment. CXCR4 overexpression has been shown in a variety of cancers. In this study, we evaluate the potential value of [68Ga]Ga-Pentixafor as a PET/CT CXCR4-probe for in vivo assessment of CXCR4 expression in patients with high-grade glioma and its correlation with tumor grade.[68Ga]Ga-CXCR4 PET/CT was performed in the prospective single-center study in treatment-naïve biopsy-proven patients with high-grade glioma. The acquired images were analyzed qualitatively and semi-quantitatively.MATERIALS AND METHODS[68Ga]Ga-CXCR4 PET/CT was performed in the prospective single-center study in treatment-naïve biopsy-proven patients with high-grade glioma. The acquired images were analyzed qualitatively and semi-quantitatively.A total of 26 patients (mean age: 53.3±14.4 years, 11 women, 15 men) were enrolled. CNS WHO grade 3 pathology was seen in 19 % (5/26) of the sample. The patient-based sensitivity of 68Ga-CXCR4 was 96.2 %. Overall, 28 pathologic lesions were detected, leading to a lesion-based sensitivity of 96.4 %. The median (IQR) SUVmax of grade 4 lesions was substantially greater than the grade 3(3.03(2.5-3.7) vs. 1.51(1.2-1.8), p = 0.0145).). The highest tracer activity of organs -beside bladder as the main excretion reservoir-was in lymphoid tissue of Waldeyer's ring (mean SUVmax: 7.41), and spleen (mean SUVmax: 6.62).RESULTA total of 26 patients (mean age: 53.3±14.4 years, 11 women, 15 men) were enrolled. CNS WHO grade 3 pathology was seen in 19 % (5/26) of the sample. The patient-based sensitivity of 68Ga-CXCR4 was 96.2 %. Overall, 28 pathologic lesions were detected, leading to a lesion-based sensitivity of 96.4 %. The median (IQR) SUVmax of grade 4 lesions was substantially greater than the grade 3(3.03(2.5-3.7) vs. 1.51(1.2-1.8), p = 0.0145).). The highest tracer activity of organs -beside bladder as the main excretion reservoir-was in lymphoid tissue of Waldeyer's ring (mean SUVmax: 7.41), and spleen (mean SUVmax: 6.62).In conclusion, this new application for [68Ga]Ga-Pentixafor PET tracer exhibits excellent visual and semi-quantitative diagnostic properties. Further studies are warranted.CONCLUSIONIn conclusion, this new application for [68Ga]Ga-Pentixafor PET tracer exhibits excellent visual and semi-quantitative diagnostic properties. Further studies are warranted.</description><issn>1872-7727</issn><issn>1872-7727</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNqVjzurwkAUhBdR8PkLbE5pk7i7xjzq4PWWIilsRBY9WTcku3FPBH--gWthe6sZ-GYGhrGl4KHgIl5XIVZe3ULJZRQKIeIsGrCJSBMZJIlMhl9-zKZEFed8G2Vyws5xCnu1V0F-yo8RHHbFOi_ANEobq8FYuBt9D3Q_jqBr4xoFpfOgiJCoQduBK-Gv6_GKbddDfLW-p8bZORuVqiZcfHTGVj-7Iv8NWu8eT6Tu0hi6Yl0ri-5Jlw3PspRv-0ubf0TfrkBNLQ</recordid><startdate>20241101</startdate><enddate>20241101</enddate><creator>Roustaei, Hessamoddin</creator><creator>Vosoughi, Habibeh</creator><creator>Askari, Emran</creator><creator>Aziz Kalantari, Bagher</creator><creator>Norouzbeigi, Nasim</creator><creator>Anvari, Kazem</creator><creator>Beheshti, Mohsen</creator><creator>Aryana, Kamran</creator><scope>7X8</scope></search><sort><creationdate>20241101</creationdate><title>68 GaGa-CXCR4 PET/CT imaging in high-grade glioma for assessment of CXCR4 receptor expression</title><author>Roustaei, Hessamoddin ; Vosoughi, Habibeh ; Askari, Emran ; Aziz Kalantari, Bagher ; Norouzbeigi, Nasim ; Anvari, Kazem ; Beheshti, Mohsen ; Aryana, Kamran</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_miscellaneous_30998050163</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Roustaei, Hessamoddin</creatorcontrib><creatorcontrib>Vosoughi, Habibeh</creatorcontrib><creatorcontrib>Askari, Emran</creatorcontrib><creatorcontrib>Aziz Kalantari, Bagher</creatorcontrib><creatorcontrib>Norouzbeigi, Nasim</creatorcontrib><creatorcontrib>Anvari, Kazem</creatorcontrib><creatorcontrib>Beheshti, Mohsen</creatorcontrib><creatorcontrib>Aryana, Kamran</creatorcontrib><collection>MEDLINE - Academic</collection><jtitle>European journal of radiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Roustaei, Hessamoddin</au><au>Vosoughi, Habibeh</au><au>Askari, Emran</au><au>Aziz Kalantari, Bagher</au><au>Norouzbeigi, Nasim</au><au>Anvari, Kazem</au><au>Beheshti, Mohsen</au><au>Aryana, Kamran</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>68 GaGa-CXCR4 PET/CT imaging in high-grade glioma for assessment of CXCR4 receptor expression</atitle><jtitle>European journal of radiology</jtitle><date>2024-11-01</date><risdate>2024</risdate><volume>180</volume><spage>111694</spage><pages>111694-</pages><issn>1872-7727</issn><eissn>1872-7727</eissn><abstract>Gliomas account for 75 % of primary malignant CNS tumors. High-grade glioma (CNS WHO grades 3 and 4) have an unfavorable treatment response and poor outcome. CXCR4 is a G protein-coupled receptor that plays an important part in the signaling pathway between cancer cells and tumor microenvironment. CXCR4 overexpression has been shown in a variety of cancers. In this study, we evaluate the potential value of [68Ga]Ga-Pentixafor as a PET/CT CXCR4-probe for in vivo assessment of CXCR4 expression in patients with high-grade glioma and its correlation with tumor grade.PURPOSEGliomas account for 75 % of primary malignant CNS tumors. High-grade glioma (CNS WHO grades 3 and 4) have an unfavorable treatment response and poor outcome. CXCR4 is a G protein-coupled receptor that plays an important part in the signaling pathway between cancer cells and tumor microenvironment. CXCR4 overexpression has been shown in a variety of cancers. In this study, we evaluate the potential value of [68Ga]Ga-Pentixafor as a PET/CT CXCR4-probe for in vivo assessment of CXCR4 expression in patients with high-grade glioma and its correlation with tumor grade.[68Ga]Ga-CXCR4 PET/CT was performed in the prospective single-center study in treatment-naïve biopsy-proven patients with high-grade glioma. The acquired images were analyzed qualitatively and semi-quantitatively.MATERIALS AND METHODS[68Ga]Ga-CXCR4 PET/CT was performed in the prospective single-center study in treatment-naïve biopsy-proven patients with high-grade glioma. The acquired images were analyzed qualitatively and semi-quantitatively.A total of 26 patients (mean age: 53.3±14.4 years, 11 women, 15 men) were enrolled. CNS WHO grade 3 pathology was seen in 19 % (5/26) of the sample. The patient-based sensitivity of 68Ga-CXCR4 was 96.2 %. Overall, 28 pathologic lesions were detected, leading to a lesion-based sensitivity of 96.4 %. The median (IQR) SUVmax of grade 4 lesions was substantially greater than the grade 3(3.03(2.5-3.7) vs. 1.51(1.2-1.8), p = 0.0145).). The highest tracer activity of organs -beside bladder as the main excretion reservoir-was in lymphoid tissue of Waldeyer's ring (mean SUVmax: 7.41), and spleen (mean SUVmax: 6.62).RESULTA total of 26 patients (mean age: 53.3±14.4 years, 11 women, 15 men) were enrolled. CNS WHO grade 3 pathology was seen in 19 % (5/26) of the sample. The patient-based sensitivity of 68Ga-CXCR4 was 96.2 %. Overall, 28 pathologic lesions were detected, leading to a lesion-based sensitivity of 96.4 %. The median (IQR) SUVmax of grade 4 lesions was substantially greater than the grade 3(3.03(2.5-3.7) vs. 1.51(1.2-1.8), p = 0.0145).). The highest tracer activity of organs -beside bladder as the main excretion reservoir-was in lymphoid tissue of Waldeyer's ring (mean SUVmax: 7.41), and spleen (mean SUVmax: 6.62).In conclusion, this new application for [68Ga]Ga-Pentixafor PET tracer exhibits excellent visual and semi-quantitative diagnostic properties. Further studies are warranted.CONCLUSIONIn conclusion, this new application for [68Ga]Ga-Pentixafor PET tracer exhibits excellent visual and semi-quantitative diagnostic properties. Further studies are warranted.</abstract><doi>10.1016/j.ejrad.2024.111694</doi></addata></record>
fulltext fulltext
identifier ISSN: 1872-7727
ispartof European journal of radiology, 2024-11, Vol.180, p.111694
issn 1872-7727
1872-7727
language eng
recordid cdi_proquest_miscellaneous_3099805016
source Access via ScienceDirect (Elsevier)
title 68 GaGa-CXCR4 PET/CT imaging in high-grade glioma for assessment of CXCR4 receptor expression
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-11T23%3A43%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=68%20GaGa-CXCR4%20PET/CT%20imaging%20in%20high-grade%20glioma%20for%20assessment%20of%20CXCR4%20receptor%20expression&rft.jtitle=European%20journal%20of%20radiology&rft.au=Roustaei,%20Hessamoddin&rft.date=2024-11-01&rft.volume=180&rft.spage=111694&rft.pages=111694-&rft.issn=1872-7727&rft.eissn=1872-7727&rft_id=info:doi/10.1016/j.ejrad.2024.111694&rft_dat=%3Cproquest%3E3099805016%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3099805016&rft_id=info:pmid/&rfr_iscdi=true